https://www.healthbulletinhaiti.com/article/911623454-carbogen-amcis-nmpa-gmp Health Bulletin Haiti en PressRelease 2026-05-09T11:28:47+00:00 CARBOGEN AMCIS 上海工厂顺利通过 NMPA GMP 突击检查 https://ml-eu.globenewswire.com/media/92719929-fcdb-45ec-80e1-cc5636960ddc/small/cgam-colour-resized-jpg.jpg https://www.healthbulletinhaiti.com/article/911623475-asuno-launches-sleep-energy-patches-to-address-rising-consumer-demand-for-wellness-solutions Health Bulletin Haiti en PressRelease 2026-05-09T11:16:33+00:00 Asuno Launches Sleep & Energy Patches to Address Rising Consumer Demand for Wellness Solutions https://ml.globenewswire.com/media/d65e9d1d-b571-4246-86b7-67686ad2eaf7/medium/asuno.jpg https://www.healthbulletinhaiti.com/article/911523470-ispecimen-inc-announces-pricing-of-approximately-2-5-million-private-placement Health Bulletin Haiti en PressRelease 2026-05-09T01:04:00+00:00 iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement https://ml.globenewswire.com/media/MWMwZjE2YjEtYTE0Yy00NGY4LTljODctMDk0YTk0ZmI5N2E5LTUwMDEzMTIwMy0yMDI2LTA1LTA5LWVu/tiny/iSpecimen-Inc-.png https://www.healthbulletinhaiti.com/article/911523439-open-peer-review-exposes-upv-ethics-committee-s-dilemma-suppress-a-33-year-recognized-breakthrough-or-acknowledge-reviewer-s-ethical-violations-and Health Bulletin Haiti en PressRelease 2026-05-09T00:24:14+00:00 Open Peer-Review Exposes UPV Ethics Committee’s Dilemma: Suppress a 33 Year Recognized Breakthrough or Acknowledge Reviewer’s Ethical Violations and Remit Final Judgement to the Known Dataset Test to Save Millions of Lives and Billions of Euros https://ml.globenewswire.com/media/40547009-5c5a-4f07-8621-de7e67578439/small/crosetto-foundation-logo-265-pixels-jpg.jpg https://www.healthbulletinhaiti.com/article/911507261-electrocore-to-present-at-the-ld-micro-invitational-xvi-conference-on-may-18-2026 Health Bulletin Haiti en PressRelease 2026-05-09T00:00:00+00:00 electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026 https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg https://www.healthbulletinhaiti.com/article/911490631-fda-expands-approval-of-vyvgart-and-vyvgart-hytrulo-to-all-adults-living-with-generalized-myasthenia-gravis Health Bulletin Haiti en PressRelease 2026-05-08T22:27:12+00:00 FDA Expands Approval of VYVGART and VYVGART Hytrulo to All Adults Living with Generalized Myasthenia Gravis https://ml.globenewswire.com/media/YjJmNDYwNjUtMzcyOS00OGUxLTlhZGEtNDU1NmI4YjQxMTE1LTEwOTg0NjYtMjAyNi0wNS0wOC1lbg==/tiny/Muscular-Dystrophy-Association.png https://www.healthbulletinhaiti.com/article/911474186-argenx-announces-u-s-fda-approval-expanding-vyvgart-and-vyvgart-hytrulo-for-use-in-all-adult-patients-living-with-gmg Health Bulletin Haiti en PressRelease 2026-05-08T21:20:00+00:00 argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png https://www.healthbulletinhaiti.com/article/911474620-fda-grants-seventh-approval-under-the-national-priority-voucher-pilot-program Health Bulletin Haiti en PressRelease 2026-05-08T21:00:59+00:00 FDA Grants Seventh Approval under the National Priority Voucher Pilot Program https://ml.globenewswire.com/media/M2FmNTlkNzctMTZlNi00NzQwLTk2OTctN2NmY2JiYzZhNTExLTUwMDE1NDE1NC0yMDI2LTA1LTA4LWVu/tiny/FDA.png https://www.healthbulletinhaiti.com/article/911474308-premier-health-announces-termination-of-forbearance-agreements-with-principal-lenders-and-the-continuance-of-its-strategic-review-process Health Bulletin Haiti en PressRelease 2026-05-08T21:00:00+00:00 Premier Health Announces Termination of Forbearance Agreements With Principal Lenders and the Continuance of Its Strategic Review Process https://ml.globenewswire.com/media/b01bbc61-42f9-4000-9a0a-b1d6719f7396/small/pha-logo-png.png https://www.healthbulletinhaiti.com/article/911474191-fulcrum-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-08T20:30:00+00:00 Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/3434fc83-4bcf-4d3c-ae26-23e5b1fd4252/small/fulcrum-logo-primary-full-color-rgb-large-png.png https://www.healthbulletinhaiti.com/article/911474276-mink-therapeutics-to-report-first-quarter-2026-financial-results-and-highlight-platform-progress-across-inkt-cell-therapy-programs Health Bulletin Haiti en PressRelease 2026-05-08T20:30:00+00:00 MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therapy Programs https://ml.globenewswire.com/media/6aa8e960-515a-40d6-9894-39ca47f5c84e/small/mink-logo-loyal-blue-and-light-blue-png.png https://www.healthbulletinhaiti.com/article/911474434-azalea-therapeutics-announces-late-breaking-oral-presentation-at-asgct-annual-meeting-demonstrating-first-in-primate-in-vivo-trac-car-t-cell Health Bulletin Haiti en PressRelease 2026-05-08T20:30:00+00:00 Azalea Therapeutics Announces Late-Breaking Oral Presentation at ASGCT Annual Meeting Demonstrating First-in-Primate In Vivo TRAC-CAR T Cell Engineering https://ml.globenewswire.com/media/074db8ed-c280-47d0-8c17-f1980e6b4ad3/small/azalea-therapeutics-logo-1200x353-png.png https://www.healthbulletinhaiti.com/article/911474524-fda-issues-guidance-to-improve-collection-of-pregnancy-safety-data-for-drugs-and-biologics Health Bulletin Haiti en PressRelease 2026-05-08T20:24:44+00:00 FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics https://ml.globenewswire.com/media/MDU4NGIzYzgtOWZkYy00MmNkLWJkYTAtZjMxYzAwMmMxYTE0LTUwMDE1NDE1NC0yMDI2LTA1LTA4LWVu/tiny/FDA.png https://www.healthbulletinhaiti.com/article/911474239-vtv-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-08T20:15:00+00:00 vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/27198d2d-fdd5-4f74-8f54-7a9e5876e06d/small/vtv-therapeutics-color-jpg.jpg https://www.healthbulletinhaiti.com/article/911474168-invitation-to-attend-the-annual-and-the-extraordinary-shareholders-meetings-of-the-company-to-be-held-on-june-10-2026 Health Bulletin Haiti en PressRelease 2026-05-08T20:05:00+00:00 Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026 https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/logo-nyxoah-rgb-png.png https://www.healthbulletinhaiti.com/article/911474172-invitation-assister-l-assembl-e-g-n-rale-annuelle-et-extraordinaire-des-actionnaires-de-la-soci-t-qui-se-tiendra-le-10-juin-2026 Health Bulletin Haiti en PressRelease 2026-05-08T20:05:00+00:00 Invitation à assister à l'assemblée générale annuelle et extraordinaire des actionnaires de la Société qui se tiendra le 10 juin 2026 https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/ https://www.healthbulletinhaiti.com/article/911474196-vera-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-08T20:05:00+00:00 Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/25b71017-1f55-4adb-9d6a-17c2ba55b36e/small/cropped-logo-digital-png.png https://www.healthbulletinhaiti.com/article/911474206-femasys-announces-financial-results-for-quarter-ended-march-31-2026-and-provides-corporate-update Health Bulletin Haiti en PressRelease 2026-05-08T20:05:00+00:00 Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update https://ml.globenewswire.com/media/c668c3db-ff7f-4eb5-b51a-b8db25e838b4/small/femasys-logo-2-jpg.jpg https://www.healthbulletinhaiti.com/article/911474223-entera-announces-first-quarter-2026-financial-results-and-updates-across-its-oral-peptide-programs Health Bulletin Haiti en PressRelease 2026-05-08T20:05:00+00:00 Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs https://ml.globenewswire.com/media/9b4ae2bf-733d-4180-b48c-d0fa3f26c81a/small/logo-png.png https://www.healthbulletinhaiti.com/article/911474252-tenax-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-08T20:05:00+00:00 Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/d8c1d3b1-51a5-4835-a9e8-6d5bce14917e/small/tenax-logo-rgb-color-jpg.jpg https://www.healthbulletinhaiti.com/article/911474273-ocular-therapeutix-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-08T20:05:00+00:00 Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/911474329-tomi-environmental-solutions-inc-reports-first-quarter-2026-financial-results-and-announces-transformative-letter-of-intent-to-merge-with-carbonium Health Bulletin Haiti en PressRelease 2026-05-08T20:05:00+00:00 TOMI Environmental Solutions, Inc. Reports First Quarter 2026 Financial Results and Announces Transformative Letter of Intent to Merge with Carbonium Core, Inc. https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://www.healthbulletinhaiti.com/article/911474339-longeveron-announces-constructive-type-c-meeting-with-u-s-fda-ahead-of-data-readout-for-elpis-ii-phase-2b-clinical-trial-evaluating-treatment-for Health Bulletin Haiti en PressRelease 2026-05-08T20:05:00+00:00 Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS) https://ml.globenewswire.com/media/a6d6e61c-2a7d-4b22-954b-04b9841fbc38/small/longeveron-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/911474376-james-cacioppo-files-updated-early-warning-report Health Bulletin Haiti en PressRelease 2026-05-08T20:05:00+00:00 James Cacioppo Files Updated Early Warning Report https://ml.globenewswire.com/media/e65f15fd-322c-4847-83c5-ceafe27f97d5/small/jushi-png.png https://www.healthbulletinhaiti.com/article/911474203-bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-08T20:01:00+00:00 BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.healthbulletinhaiti.com/article/911474216-arcutis-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-08T20:00:00+00:00 Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/1b166f47-afb1-44f1-91be-2d73e97c0ec3/small/arcutis-logo-png.png https://www.healthbulletinhaiti.com/article/911474472-biofrontera-inc-to-report-first-quarter-2026-financial-results-and-host-a-conference-call-on-may-14-2026 Health Bulletin Haiti en PressRelease 2026-05-08T20:00:00+00:00 Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026 https://ml.globenewswire.com/media/4af5197e-340e-4307-892b-382a1d29ae45/small/logo-png.png https://www.healthbulletinhaiti.com/article/911457438-shiny-smile-veneers-under-investigation-evaluating-the-dentist-designed-custom-fit-snap-on-top-bottom-veneer-claims Health Bulletin Haiti en PressRelease 2026-05-08T19:51:07+00:00 Shiny Smile Veneers Under Investigation: Evaluating the Dentist-Designed Custom Fit Snap-On Top & Bottom Veneer Claims https://zingfast.com/wp-content/uploads/2026/05/Shiny-Smile-Veneers.jpg https://www.healthbulletinhaiti.com/article/911457434-fitness-online-named-best-fitness-mobile-app-in-10th-annual-medtech-breakthrough-awards-program Health Bulletin Haiti en PressRelease 2026-05-08T19:29:53+00:00 Fitness Online Named “Best Fitness Mobile App” in 10th Annual MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.healthbulletinhaiti.com/article/911457397-major-shareholder-announcement Health Bulletin Haiti en PressRelease 2026-05-08T19:05:12+00:00 Major Shareholder Announcement https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg https://www.healthbulletinhaiti.com/article/911457422-her-bodhi-claims-evaluated-meno-hormonal-support-for-women-by-herbodhi-under-investigation Health Bulletin Haiti en PressRelease 2026-05-08T18:46:22+00:00 Her Bodhi Claims Evaluated: Meno & Hormonal Support for Women by HerBodhi Under Investigation https://zingfast.com/wp-content/uploads/2026/05/Her-Bodhi.jpg https://www.healthbulletinhaiti.com/article/911439926-more-life-summit-2026-brings-the-world-s-leading-voices-in-longevity-performance-faith-purpose-to-miami-this-october Health Bulletin Haiti en PressRelease 2026-05-08T17:12:36+00:00 More Life Summit 2026 Brings the World's Leading Voices in Longevity, Performance, Faith & Purpose to Miami this October https://ml.globenewswire.com/media/6f384cad-1646-4d58-bf63-e08230833288/medium/more-life-summit-2026-miami-fl.png https://www.healthbulletinhaiti.com/article/911404232-erdem-health-group-enters-t-rkiye-s-turquality-program Health Bulletin Haiti en PressRelease 2026-05-08T15:00:00+00:00 Erdem Health Group Enters Türkiye’s TURQUALITY Program https://ml-eu.globenewswire.com/media/6d9ebfda-b492-4767-8803-0c83321cdd01/medium/cakmak-erdem-hospital.jpg https://www.healthbulletinhaiti.com/article/911404291-cytokinetics-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares-for Health Bulletin Haiti en PressRelease 2026-05-08T14:51:36+00:00 Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.healthbulletinhaiti.com/article/911386290-inspire-named-best-patient-experience-platform-in-10th-annual-medtech-breakthrough-awards-program Health Bulletin Haiti en PressRelease 2026-05-08T14:10:00+00:00 Inspire Named “Best Patient Experience Platform” in 10th Annual MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/OWVkODQ2MTktZDk0YS00M2Q0LWJlYmItYTIyYTRjMTgxZDUzLTUwMDEyOTE4NC0yMDI2LTA1LTA4LWVu/tiny/Inspire.png https://www.healthbulletinhaiti.com/article/911386518-ai-technology-transforms-cannabis-industry-as-leading-operators-drive-adoption-to-enhance-yields-and-compliance Health Bulletin Haiti en PressRelease 2026-05-08T13:52:16+00:00 AI Technology Transforms Cannabis Industry as Leading Operators Drive Adoption to Enhance Yields and Compliance https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.healthbulletinhaiti.com/article/911386301-merit-medical-to-participate-in-the-bank-of-america-healthcare-conference Health Bulletin Haiti en PressRelease 2026-05-08T13:25:00+00:00 Merit Medical to Participate in the Bank of America Healthcare Conference https://ml.globenewswire.com/media/19958d8f-47a4-44f3-a780-247335a68768/small/merit-medical-systems-inc-logo.jpg https://www.healthbulletinhaiti.com/article/911386310-envue-medical-adds-to-intellectual-property-portfolio-by-securing-uspto-notice-of-allowance-for-ultrasound-enhanced-cannabinoid-drug-delivery Health Bulletin Haiti en PressRelease 2026-05-08T13:15:00+00:00 ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology https://ml.globenewswire.com/media/e0a97028-a7c3-4dd6-a13f-a55e43617883/small/logo-small-722-jpg.jpg https://www.healthbulletinhaiti.com/article/911370850-alpha-tau-to-host-conference-call-to-discuss-interim-results-from-first-three-patients-treated-for-recurrent-glioblastoma Health Bulletin Haiti en PressRelease 2026-05-08T13:10:00+00:00 Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/911370178-philips-shareholders-approve-all-proposals-at-the-agm-2026 Health Bulletin Haiti en PressRelease 2026-05-08T13:01:04+00:00 Philips shareholders approve all proposals at the AGM 2026 https://ml-eu.globenewswire.com/media/e5826782-01bc-45e7-b448-9ca1eae0125e/small/philips-logo-logotype-emblem-700x128-png.png https://www.healthbulletinhaiti.com/article/911370587-bioage-labs-reports-first-quarter-2026-financial-results-and-provides-business-updates Health Bulletin Haiti en PressRelease 2026-05-08T13:00:00+00:00 BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png https://www.healthbulletinhaiti.com/article/911370826-alpha-tau-completes-patient-enrollment-in-its-u-s-pivotal-skin-cancer-study-advancing-towards-goal-of-fda-approval-of-alpha-dart-to-treat-recurrent Health Bulletin Haiti en PressRelease 2026-05-08T13:00:00+00:00 Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/911370911-j-star-holding-signs-mou-with-white-group-to-advance-financing-for-texas-solid-state-battery-facility Health Bulletin Haiti en PressRelease 2026-05-08T13:00:00+00:00 J-Star Holding Signs MOU with White Group to Advance Financing for Texas Solid-State Battery Facility https://ml.globenewswire.com/media/1a4c6faf-93be-4d28-a35f-1df9c4f0404e/small/j-star-logo-blue-transparent-png.png https://www.healthbulletinhaiti.com/article/911370159-allarity-therapeutics-ceo-to-present-at-precision-medicine-forum-europe-2026-in-stockholm Health Bulletin Haiti en PressRelease 2026-05-08T12:45:00+00:00 Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm https://ml-eu.globenewswire.com/media/fd1e4c64-f0cf-40e0-a0c9-0be0d6dce544/small/allarity-full-color-rgb-2023jun07-png.png https://www.healthbulletinhaiti.com/article/911370672-moleculin-biotech-secures-strategic-additional-patent-strengthening-global-positioning-of-annamycin Health Bulletin Haiti en PressRelease 2026-05-08T12:45:00+00:00 Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png https://www.healthbulletinhaiti.com/article/911371106-aim-immunotech-inc-announces-exercise-of-warrants-for-approx-4-2-million-in-gross-proceeds Health Bulletin Haiti en PressRelease 2026-05-08T12:40:00+00:00 AIM ImmunoTech, Inc. Announces Exercise of Warrants for Approx. $4.2 Million in Gross Proceeds https://ml.globenewswire.com/media/8e85b83b-047f-4f99-9c51-1aa232ffe9bb/small/aimlogo-jpg.jpg https://www.healthbulletinhaiti.com/article/911370349-aclaris-therapeutics-to-participate-in-the-2026-bank-of-america-healthcare-conference Health Bulletin Haiti en PressRelease 2026-05-08T12:30:00+00:00 Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference https://ml.globenewswire.com/media/de2bcb21-de59-4226-bc8b-b1b747461f51/small/aclaris-logo-clr-jpg.jpg https://www.healthbulletinhaiti.com/article/911370612-prenetics-to-report-q1-2026-financial-results-on-may-14-2026-and-host-earnings-conference-call Health Bulletin Haiti en PressRelease 2026-05-08T12:30:00+00:00 Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call https://ml.globenewswire.com/media/106dbe1a-a6e1-49d9-97a2-c5609258bdc7/small/pre-logo-2026-png.png https://www.healthbulletinhaiti.com/article/911370712-cg-oncology-reports-first-quarter-2026-financial-results-and-provides-business-updates Health Bulletin Haiti en PressRelease 2026-05-08T12:30:00+00:00 CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/9e1cbdea-928e-4ea4-b4cd-33cdc36c6b2f/small/cgoncology-cover-jpg.jpg https://www.healthbulletinhaiti.com/article/911370964-inflarx-announces-closing-of-150-million-underwritten-offering-of-ordinary-shares Health Bulletin Haiti en PressRelease 2026-05-08T12:15:00+00:00 InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://www.healthbulletinhaiti.com/article/911370316-mimedx-announces-launch-of-g4derm-plus Health Bulletin Haiti en PressRelease 2026-05-08T12:00:00+00:00 MIMEDX Announces Launch of G4Derm® Plus https://ml.globenewswire.com/media/2a60ab36-4917-479c-b53a-4f2113ca347d/small/mimedx-png.png https://www.healthbulletinhaiti.com/article/911370604-humacyte-to-announce-2026-first-quarter-financial-results-and-provide-business-update-on-may-13-2026 Health Bulletin Haiti en PressRelease 2026-05-08T12:00:00+00:00 Humacyte To Announce 2026 First Quarter Financial Results and Provide Business Update on May 13, 2026 https://ml.globenewswire.com/media/e81aff26-ead8-404d-aebb-159b45c3e7b1/small/huma-logo-png.png https://www.healthbulletinhaiti.com/article/911370607-alx-oncology-reports-first-quarter-2026-financial-results-and-provides-corporate-update Health Bulletin Haiti en PressRelease 2026-05-08T12:00:00+00:00 ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/0a1b4459-3df3-4c9f-ba29-ace8d7ad1b9a/small/alx-01-stacked-white-png.png https://www.healthbulletinhaiti.com/article/911370619-integra-lifesciences-to-present-at-the-bofa-securities-2026-health-care-conference Health Bulletin Haiti en PressRelease 2026-05-08T12:00:00+00:00 Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference https://ml.globenewswire.com/media/80d27f1a-2d8e-44f2-92e9-57e14db38652/small/integra-promotional-logos-integra-logo-full-color-process-1.png https://www.healthbulletinhaiti.com/article/911370636-pacira-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-08T12:00:00+00:00 Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://www.healthbulletinhaiti.com/article/911370805-biocardia-and-fda-align-on-helix-transendocardial-delivery-catheter-clearance-pathways Health Bulletin Haiti en PressRelease 2026-05-08T12:00:00+00:00 BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways https://ml.globenewswire.com/media/4641bb53-4913-4654-a337-79383a5c7ab9/small/biocardia-final-logo-2016-jpeg-jpg.jpg https://www.healthbulletinhaiti.com/article/911370907-alamar-biosciences-reports-first-quarter-2026-financial-results Health Bulletin Haiti en PressRelease 2026-05-08T12:00:00+00:00 Alamar Biosciences Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/9394cf1d-76c7-4cf9-8ed3-cafcc57c9a84/small/alamardroplogo-4c-png.png https://www.healthbulletinhaiti.com/article/911355251-plus-therapeutics-announces-oral-presentation-highlighting-reyobiq-clinical-and-translational-data-demonstrating-favorable-safety-survival-and Health Bulletin Haiti en PressRelease 2026-05-08T11:30:00+00:00 Plus Therapeutics Announces Oral Presentation Highlighting REYOBIQ™ Clinical and Translational Data Demonstrating Favorable Safety, Survival, and Emerging Immunomodulation in Leptomeningeal Metastases https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://www.healthbulletinhaiti.com/article/911355675-avicanna-announces-results-of-annual-general-and-special-meeting Health Bulletin Haiti en PressRelease 2026-05-08T11:30:00+00:00 Avicanna Announces Results of Annual General and Special Meeting https://ml.globenewswire.com/media/c9abc2f4-efdc-40f6-921d-a5da048eda46/small/avicanna-logo-colour-withtm-01-png.png https://www.healthbulletinhaiti.com/article/911355689-traws-pharma-to-advance-potential-clinical-candidates-for-the-treatment-of-hantavirus-infections Health Bulletin Haiti en PressRelease 2026-05-08T11:30:00+00:00 Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections https://ml.globenewswire.com/media/1eb1780a-724e-4555-ab4d-455e27d18544/small/traws-pharma-blue-png.png https://www.healthbulletinhaiti.com/article/911355706-spectral-medical-announces-first-quarter-2026-financial-results-and-provides-corporate-update Health Bulletin Haiti en PressRelease 2026-05-08T11:30:00+00:00 Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/9516c02b-7f3b-41c0-bac1-a037af9a3240/small/new-spectral-logo-rgb-jpg.jpg https://www.healthbulletinhaiti.com/article/911355617-treace-medical-concepts-reports-first-quarter-2026-financial-results Health Bulletin Haiti en PressRelease 2026-05-08T11:05:00+00:00 Treace Medical Concepts Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/e6af4ccc-19b1-4fe0-948f-436f2b9d2ea5/small/treace-color-jpg.jpg https://www.healthbulletinhaiti.com/article/911355088-oxb-to-exhibit-and-present-at-the-30th-annual-meeting-of-the-american-society-of-cell-and-gene-therapy-asgct Health Bulletin Haiti en PressRelease 2026-05-08T11:00:00+00:00 OXB to exhibit and present at the 30th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT) https://ml-eu.globenewswire.com/media/3e905c0a-b28c-4981-ac57-745647779ad9/small/oxb-new-logo-png.png https://www.healthbulletinhaiti.com/article/911355200-le-consortium-international-de-recherche-sur-le-cancer-de-l-ovaire-annonce-une-nouvelle-bourse-pour-des-recherches-propuls-es-par-l-ia-visant-faire Health Bulletin Haiti en PressRelease 2026-05-08T11:00:00+00:00 Le Consortium international de recherche sur le cancer de l’ovaire annonce une nouvelle bourse pour des recherches propulsées par l’IA, visant à faire progresser les découvertes fondées sur les données https://ml.globenewswire.com/media/6d2e71b6-7ea9-4218-b59d-c718b24d7382/small/occ-logo-fr-clr-rgb-png.png https://www.healthbulletinhaiti.com/article/911355203-global-ovarian-cancer-research-consortium-announces-next-ai-accelerator-grant-to-advance-data-driven-discovery Health Bulletin Haiti en PressRelease 2026-05-08T11:00:00+00:00 Global Ovarian Cancer Research Consortium Announces Next AI Accelerator Grant to Advance Data-Driven Discovery https://ml.globenewswire.com/media/de07035a-bbf6-48bd-b4ea-ec41c0d06771/small/occ-logo-en-clr-rgb-1-png.png https://www.healthbulletinhaiti.com/article/911355434-lensar-reports-first-quarter-2026-results-and-provides-business-update Health Bulletin Haiti en PressRelease 2026-05-08T11:00:00+00:00 LENSAR® Reports First Quarter 2026 Results and Provides Business Update https://ml.globenewswire.com/media/4768eddf-0f87-4479-87f6-6b81f8ff392a/small/lensar-4color-jpg.jpg https://www.healthbulletinhaiti.com/article/911355605-boundless-bio-reports-first-quarter-2026-financial-results-and-business-highlights Health Bulletin Haiti en PressRelease 2026-05-08T11:00:00+00:00 Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/3b8ff619-e7af-4c58-a7f2-de0c4019068d/small/boundlessbiologo-jpg.jpg https://www.healthbulletinhaiti.com/article/911355613-regeneron-named-to-dow-jones-best-in-class-world-index-for-global-responsibility-leadership-for-seven-consecutive-years Health Bulletin Haiti en PressRelease 2026-05-08T11:00:00+00:00 Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/911355644-hyperion-defi-announces-closing-of-public-offering-of-common-stock Health Bulletin Haiti en PressRelease 2026-05-08T11:00:00+00:00 Hyperion DeFi Announces Closing of Public Offering of Common Stock https://ml.globenewswire.com/media/2b21f207-e46f-4ad9-a6be-573e0bdc6c4c/small/hyperion-defi-single-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/911355660-tvardi-therapeutics-announces-first-quarter-2026-results-and-provides-business-update Health Bulletin Haiti en PressRelease 2026-05-08T11:00:00+00:00 Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update https://ml.globenewswire.com/media/65859e40-e7db-474e-b604-78033b160f6b/small/tvardi-therapeutics-logo-1200-jpg.jpg https://www.healthbulletinhaiti.com/article/911355697-maplight-therapeutics-to-participate-in-upcoming-investor-conferences Health Bulletin Haiti en PressRelease 2026-05-08T11:00:00+00:00 MapLight Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/173b471e-5a67-4f12-84f2-06f4980ebd76/small/maplight-logo-horizontal-web-color-png.png https://www.healthbulletinhaiti.com/article/911355719-artiva-biotherapeutics-announces-pricing-of-300-million-underwritten-offering-of-common-stock-and-pre-funded-warrants Health Bulletin Haiti en PressRelease 2026-05-08T10:52:31+00:00 Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants https://ml.globenewswire.com/media/0392544b-ecff-4590-9eed-59c934e1ba4d/small/artiva-biotherapeutics-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/911355628-ani-pharmaceuticals-reports-first-quarter-2026-financial-results-and-raises-2026-financial-guidance Health Bulletin Haiti en PressRelease 2026-05-08T10:50:00+00:00 ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance https://ml.globenewswire.com/media/24d1d851-9075-4d6e-b22c-0c23a5ef0b36/small/ani-logo-png.png https://www.healthbulletinhaiti.com/article/911340646-artiva-biotherapeutics-reports-first-quarter-2026-financial-results-and-recent-business-highlights Health Bulletin Haiti en PressRelease 2026-05-08T10:31:00+00:00 Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/0392544b-ecff-4590-9eed-59c934e1ba4d/small/artiva-biotherapeutics-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/911340634-knight-therapeutics-announces-regulatory-approval-of-tavalisse-in-brazil Health Bulletin Haiti en PressRelease 2026-05-08T10:30:00+00:00 Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil https://ml.globenewswire.com/media/e9457092-692d-4bfd-b361-9799ee8d73cd/small/logo-knight-256x256px-jpg.jpg https://www.healthbulletinhaiti.com/article/911340639-th-rapeutique-knight-annonce-l-approbation-r-glementaire-de-tavalisse-au-br-sil Health Bulletin Haiti en PressRelease 2026-05-08T10:30:00+00:00 Thérapeutique Knight annonce l’approbation réglementaire de TAVALISSE® au Brésil https://ml.globenewswire.com/media/e9457092-692d-4bfd-b361-9799ee8d73cd/small/logo-knight-256x256px-jpg.jpg https://www.healthbulletinhaiti.com/article/911340666-artiva-announces-positive-initial-clinical-data-with-allonk-across-multiple-autoimmune-diseases-and-fda-alignment-to-initiate-phase-3-registrational Health Bulletin Haiti en PressRelease 2026-05-08T10:30:00+00:00 Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid Arthritis in 2026 https://ml.globenewswire.com/media/0392544b-ecff-4590-9eed-59c934e1ba4d/small/artiva-biotherapeutics-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/911340599-nxera-files-patent-infringement-action-in-relation-to-its-minig-platform-technology Health Bulletin Haiti en PressRelease 2026-05-08T10:26:31+00:00 Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://www.healthbulletinhaiti.com/article/911340746-angel-expands-u-s-water-purification-lineup-with-new-whole-house-water-filtration-systems Health Bulletin Haiti en PressRelease 2026-05-08T10:20:18+00:00 ANGEL Expands U.S. Water Purification Lineup with New Whole House Water Filtration Systems https://ml.globenewswire.com/media/c9f92ea2-5454-4357-8a0b-3955c66106f3/medium/image-1.jpeg https://www.healthbulletinhaiti.com/article/911340682-profusa-receives-favorable-nasdaq-listing-determination Health Bulletin Haiti en PressRelease 2026-05-08T10:00:00+00:00 Profusa Receives Favorable Nasdaq Listing Determination https://ml.globenewswire.com/media/a8137a61-b858-48da-9e47-1f1bf8f6ddba/small/profusa-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/911340704-pharvaris-announces-pricing-of-115-million-underwritten-offering-of-ordinary-shares Health Bulletin Haiti en PressRelease 2026-05-08T10:00:00+00:00 Pharvaris Announces Pricing of $115 Million Underwritten Offering of Ordinary Shares https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png https://www.healthbulletinhaiti.com/article/911307449-update-on-fda-priority-review-of-leqembi-iqlik-lecanemab-irmb-subcutaneous-injection-as-a-starting-dose-for-early-alzheimer-s-disease Health Bulletin Haiti en PressRelease 2026-05-08T06:30:00+00:00 Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg https://www.healthbulletinhaiti.com/article/911268606-lifestance-health-group-announces-pricing-of-secondary-public-offering Health Bulletin Haiti en PressRelease 2026-05-08T02:18:18+00:00 LifeStance Health Group Announces Pricing of Secondary Public Offering https://ml.globenewswire.com/media/08b345f0-a6a4-4217-9255-cce40df2585c/small/lifestance-logo-png.png https://www.healthbulletinhaiti.com/article/911254150-mobia-medical-announces-pricing-of-initial-public-offering Health Bulletin Haiti en PressRelease 2026-05-08T02:10:05+00:00 Mobia Medical Announces Pricing of Initial Public Offering https://ml.globenewswire.com/media/52324ae5-4190-4acb-93b4-aa6f1c996843/small/mobia-medical-logo-color-rgb-400x400-png.png https://www.healthbulletinhaiti.com/article/911239138-odyssey-therapeutics-announces-pricing-of-upsized-initial-public-offering Health Bulletin Haiti en PressRelease 2026-05-08T00:44:45+00:00 Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering https://ml.globenewswire.com/media/6da00a97-4976-4d32-9f38-cff9c4f091cf/small/odysseylogo-color-highres-png.png https://www.healthbulletinhaiti.com/article/911239126-innocare-announces-approval-of-a-phase-ii-clinical-trial-of-tyk2-inhibitor-icp-488-for-sj-gren-s-syndrome-in-china Health Bulletin Haiti en PressRelease 2026-05-08T00:30:00+00:00 InnoCare Announces Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Sjögren's Syndrome in China https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png https://www.healthbulletinhaiti.com/article/911239075-medipharm-labs-sets-date-to-report-first-quarter-2026-financial-results Health Bulletin Haiti en PressRelease 2026-05-08T00:05:00+00:00 MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results https://ml.globenewswire.com/media/7a534238-60aa-4187-979d-8f4d83fa58c1/small/medipharm-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/911222901-cue-biopharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-05-07T23:07:21+00:00 Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://www.healthbulletinhaiti.com/article/911222877-novi-glp-1-weight-loss-claims-evaluated-trusted-semaglutide-tirzepatide-prescription-medication-treatment-options-with-dedicated-doctors Health Bulletin Haiti en PressRelease 2026-05-07T22:50:39+00:00 Novi GLP-1 Weight Loss Claims Evaluated: Trusted Semaglutide & Tirzepatide Prescription Medication Treatment Options with Dedicated Doctors https://zingfast.com/wp-content/uploads/2026/05/Novi-GLP-1-Weight-Loss.jpg https://www.healthbulletinhaiti.com/article/911207186-biosyent-schedules-first-quarter-2026-earnings-release-for-may-14-2026 Health Bulletin Haiti en PressRelease 2026-05-07T22:11:05+00:00 BioSyent Schedules First Quarter 2026 Earnings Release for May 14, 2026 https://ml.globenewswire.com/media/3dded277-7953-4418-be63-7d7a3067811d/small/biosyent-logo-png.png https://www.healthbulletinhaiti.com/article/911207122-vitalhub-reports-first-quarter-2026-results Health Bulletin Haiti en PressRelease 2026-05-07T21:55:00+00:00 VitalHub Reports First Quarter 2026 Results https://ml.globenewswire.com/media/fae8da93-7d5e-4eb4-9121-d724c8555bce/small/greylogo-png.png https://www.healthbulletinhaiti.com/article/911207124-vitalhub-announces-planned-board-succession-with-appointment-of-allan-brett-as-chairman Health Bulletin Haiti en PressRelease 2026-05-07T21:55:00+00:00 VitalHub Announces Planned Board Succession with Appointment of Allan Brett as Chairman https://ml.globenewswire.com/media/fae8da93-7d5e-4eb4-9121-d724c8555bce/small/greylogo-png.png https://www.healthbulletinhaiti.com/article/911207026-extendicare-announces-2026-first-quarter-results Health Bulletin Haiti en PressRelease 2026-05-07T21:24:42+00:00 Extendicare Announces 2026 First Quarter Results https://ml.globenewswire.com/media/6d631964-eede-4e2c-912c-58ab7d1dc35f/small/extendicare-jpg.jpg https://www.healthbulletinhaiti.com/article/911190966-lemaitre-to-present-at-the-bank-of-america-healthcare-conference Health Bulletin Haiti en PressRelease 2026-05-07T21:15:30+00:00 LeMaitre to Present at the Bank of America Healthcare Conference https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg https://www.healthbulletinhaiti.com/article/911190225-nova-leap-health-corp-posts-q1-2026-results Health Bulletin Haiti en PressRelease 2026-05-07T21:00:00+00:00 Nova Leap Health Corp. Posts Q1 2026 Results https://ml.globenewswire.com/media/a1093558-bfa0-423d-827b-10c04fa3374d/medium/revenue-in-usd.png https://www.healthbulletinhaiti.com/article/911190801-tarsus-to-participate-in-upcoming-investor-conferences Health Bulletin Haiti en PressRelease 2026-05-07T21:00:00+00:00 Tarsus to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/22d429f7-9b81-4c03-a147-1d9cbc86d1dd/small/tarsus-logo-stacked-color-532x626-png.png https://www.healthbulletinhaiti.com/article/911190911-lifestance-health-group-announces-launch-of-secondary-public-offering Health Bulletin Haiti en PressRelease 2026-05-07T20:51:06+00:00 LifeStance Health Group Announces Launch of Secondary Public Offering https://ml.globenewswire.com/media/08b345f0-a6a4-4217-9255-cce40df2585c/small/lifestance-logo-png.png